Abstract
Venous angiomata, or venous malformations, are often present at birth, although they may not be evident until later. They consist of a spongy tangle of veins, and these lesions usually vary in size. Treatment of venous angiomata is often requested for cosmetic reasons, but painful ulcerations, nerve compression, functional disability can command care. This presentation describes management using sclerosant foam as the treating agent. During a 30-month period ending March 2004, 1,321 patients were investigated for venous disorders at the Vein Institute of La Jolla. Fourteen (incidence 1%) were found to have venous angiomata (nine women). The age range was 15-76 years (mean 30.8 ± 18.6). Lesions were classified by the Hamburg system and were primarily venous, extratruncular in 12 patients and combined extratruncular and truncular in two patients. Eight patients, three males, had manifestations of lower extremity Klippel-Trenaunay (syndrome; six had only venous angiomas. Only 10 of the 14 patients were treated. All patients were studied by Doppler duplex examination. Selected lesions were chosen for helical computed tomographic studies. Magnetic resonance venography was also used to image the lesions, define the deep circulation, note connections with normal circulation, identify vessels for therapeutic access, and determine infiltration of the lesion into adjacent soft tissue. Foam was produced by the Tessari two syringes one three-way stopcock teclinique, with the air to Polidocanol ratio being 4 or 5 to 1. This was used at 1% or 2% concentration, specific for each patient. The SonoSite 190 plus Duplex Doppler was used for ultrasound guidance, whenever deep access was required and to monitor progress and effects of treatment. A goal was set for each patient before treatment was begun. Ten patients were treated, and four await treatment. The mean number of treatments was 3.6 ± 2.8 (range 1-10). A primary goal of pain-free healing was set in patients with nonhealing, painful ulceration or symptomatic varicose veins. This was achieved in all treated patients. Cosmetically, all of the patients were improved, and symptomatic patients were relieved of pain. The single complication was formation of a cutaneous ulcer following injection of telangiectasias. Sclerosant foam is a satisfactory tool to use in treating venous angiomata including the Klippel-Trenaunay syndrome. Use of foam sclerotherapy in this experience has proven the technique to be effective, essentially pain-free, and durable in the short term.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Paes E, Vollmar J. Diagnosis and surgical aspects of congenital venous angiodysnplasia in the extremities. Phlebology 1995;10:160-164
Rockman CB, Rosen RJ, Jacobwitz GR, et al. Transcatheter embolization of extremity vascular malformations: the long term success of multiple interventions. Ann. Vasc. Surg. 2003;17:417-423
de Lorimier AA. Sclerotherapy for venous malformations. J. Pediatr. Surg. 1995; 30:188-194
Cabrera J, Cabrera J Jr, Garcia-Olmedio MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch. Dermatol. 2003;139:1409-1416
Samuel M, Spitz L. Klippel-Trenaunay syndrome. Clinical features, complications and management in children. Br J. Surg. 1995;82:757-762
Belov ST. Anatomopathological classification of congenital vascular defects. Semin. Vasc. Surg. 1993;6:219-224
Belov ST. Classification of congenital vascular defects. Int. Angiol. 1990;9:141-146
Hu T-S, Weiss RA. Foam sclerotherapy, a new era.Arch. Dermatol. 2003; 139:1494-1496
Goldman MP, Bergan JJ. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins, 3rd ed. St. Louis MO: Mosby, 2001
Conrad P, Malouf GM, Stacey MC. The Australian Polidocanol study: results at 2 years. Dermatol. Surg. 1995;21:344-346
Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie 1997;50:181-188
Monfreux A. Traitement sclerosant des troncs sapheniens et leurs collaterales de gros calibres par la methode MUS. Phlebologie 1997;50:351-353
Tessari L. Nouvelle teclinique d’obtention de la scero-mousse. Phlebologie 2000;53:129
Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins, telangiectases: history and analysis of safety and complications. Dermatol. Surg. 2002;28:11-15
Hamel-Desnos C, Desnos P, Ouvry P. Nouveautes therapeutiques dans la prise en charge de la maladie variqueuse: echo-sclerotherapie et mousse. Phlebologie 2003; 56:41-48
Hamel-Desnos C, Desnos P, Wollman J-C, Ouvry P, Mako S, Allaert F-A. Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol. Surg. 2003;29:1170-1175
Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind randomized study comparing chromated glycerin, Polidocanol solution, polidocanol foam for treatment of telangiectatic leg veins. Dermatol. Surg. 2004;30:367-372
Henriet JP. Experience durant 3 annees de la mousse de Polidocanol dans le traitement des varices reticularies et des varicosities. Phlebologie 1995;52:277-282
Rodriguez CJ, Homma S. Patent foramen ovale, stroke. Curr. Treat. Options Cardiovasc. Med. 2003;5:233-240
Dogan R, Faruk Dogan O, Oc M, Akata D, Gumus B, Balkanci F. A rare vascular malformation, Klippel-Trenaunay syndrome. Report of a case with deep vein agenesis, review of the literature. J. Cardiovasc. Surg. 2003;44:95-100
Eerola I, Mulliken JB, Burrows PE, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am. J. Hum. Genet. 2003;73:1240-1249,
Yamaki T, Nozaki M, Sasaki K, Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol. Surg. 2000;26:323–328
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Pascarella, L., Bergan, J., Yamada, C. et al. Venous Ansgiomata: Treatment with Sclerosant Foam. Ann Vasc Surg 19, 457–464 (2005). https://doi.org/10.1007/s10016-005-4656-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10016-005-4656-z